Canada
Czech
Germany
Indonesia
Ireland
Italy
Mexico
Poland
Singapore
Slovakia
Spain
Taiwan
United Kingdom
SportVis™
RECOVERY FROM ROTATOR CUFF TENDINOPATHY (RCT)
Here you will find detailed information why SportVis™ promotes the recovery of Rotator Cuff Tendinopathy (RCT). Take some time to browse the sections below.
About SportVis™
SportVis™ has received approval for Rotator Cuff Tendinopathy. SportVis™ is administered by a trained medical professional using antero-lateral approach to introduce the BIOCOMPATIBLE Hyaluronic Acid (STABHA™) along the injured tendon for a speedier recovery.
The main content of SportVis™ is STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid). SportVis™ is a registered product. Both SportVis™ and the manufacturing process for STABHA™ are patented.
A large clinical study conducted over a period of 6 months demonstrated the following results:
Patients with Rotator Cuff Tendinopathy had lesser pain when resting and using the shoulder up to twelve weeks after using SportVis™.
Patients with Rotator Cuff Tendinopathy had an increase in joint function up to twelve weeks after using SportVis™.
Hyaluronic acid has an ancillary effect of reducing pain and limiting inflammation.
SportVis™ containing STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid) will help reduce pain and limit inflammation in Rotator Cuff Tendinopathy.
It is recommended that patients suffering from Rotator Cuff Tendinopathy receive 2 injections of SportVis™, with the 2nd injection administrated two weeks after the 1st administration.
There is no set time frame for using SportVis™ if you are suffering from Rotator Cuff Tendinopathy.
SportVis™ introduces STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid) to the site to promote recovery. It also aids by lubricating the injury site facilitating the realignment of the injured tissue fibres to its optimised position for increased tensile strength for a speedier and better recovery.